Who can purchase medical cannabis products with higher THC levels?

Question

Accepted Answer

Terminally Ill Patients and Those Who Have Exhausted Other Treatments Can Purchase Higher THC Medical Cannabis Products

In Brazil, individuals with a prescription can now purchase medical cannabis products containing more than 0.2 per cent tetrahydrocannabinol (THC). This specific provision applies to patients who are terminally ill or who have already tried and failed to find relief through alternative medical treatments. For the general population seeking medical cannabis, products with a THC concentration below 0.2 per cent will be available for purchase with a prescription.
Higher THC Levels Permitted for Specific Patient Groups

The Brazilian Health Regulatory Agency (Anvisa) has established a new regulation that permits the sale of medical cannabis products with a THC concentration exceeding 0.2 per cent. This allowance is specifically for terminally ill patients or those who have exhausted all other available treatment options. This distinction aims to provide access to potentially more potent therapeutic cannabis for individuals with severe or end-of-life conditions.
Standard Medical Cannabis Products Available for Broader Access

For patients who do not fall into the category of terminally ill or having exhausted all other treatments, access to medical cannabis products will be restricted to those with a THC concentration of less than 0.2 per cent. This threshold ensures that the majority of medical cannabis products available for prescription remain below the psychoactive threshold that could lead to significant intoxication, aligning with a more conservative approach to general medical cannabis distribution.
Regulation Facilitates In-Pharmacy Sales and Laboratory Manufacturing

The recent regulation approved by Anvisa not only allows for the sale of these medical cannabis products in pharmacies but also permits their manufacture in laboratories. This dual approach is intended to streamline the supply chain for medical cannabis, ensuring that approved products can be produced and distributed efficiently to patients who have obtained a prescription. Anvisa is also currently evaluating the possibility of authorising the cultivation of medical cannabis.

Reading history

Hide →

This history is cleared when the page is closed.

Who can purchase medical cannabis products with higher THC levels?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends